Search by Drug Name or NDC

    NDC 42858-0040-01 HYDROCODONE BITARTRATE AND ACETAMINOPHEN 300; 5 mg/1; mg/1 Details

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN 300; 5 mg/1; mg/1

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rhodes Pharmaceuticals L.P.. The primary component is ACETAMINOPHEN; HYDROCODONE BITARTRATE.

    Product Information

    NDC 42858-0040
    Product ID 42858-040_f6fca35d-725f-4d3a-93cd-604ee8b4c439
    Associated GPIs 65991702100309
    GCN Sequence Number 060338
    GCN Sequence Number Description hydrocodone/acetaminophen TABLET 5 MG-300MG ORAL
    HIC3 H3U
    HIC3 Description OPIOID ANALGESIC AND NON-SALICYLATE ANALGESICS
    GCN 26470
    HICL Sequence Number 001730
    HICL Sequence Number Description HYDROCODONE BITARTRATE/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name HYDROCODONE BITARTRATE AND ACETAMINOPHEN
    Proprietary Name Suffix n/a
    Non-Proprietary Name HYDROCODONE BITARTRATE and ACETAMINOPHEN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300; 5
    Active Ingredient Units mg/1; mg/1
    Substance Name ACETAMINOPHEN; HYDROCODONE BITARTRATE
    Labeler Name Rhodes Pharmaceuticals L.P.
    Pharmaceutical Class Opioid Agonist [EPC], Opioid Agonists [MoA]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA207808
    Listing Certified Through 2022-12-31

    Package

    NDC 42858-0040-01 (42858004001)

    NDC Package Code 42858-040-01
    Billing NDC 42858004001
    Package 100 TABLET in 1 BOTTLE (42858-040-01)
    Marketing Start Date 2018-07-31
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.25137
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description HYDROCODONE-ACETAMINOPHEN 5-300 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis